Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FMED vs FSMEX
Shared holdings
24
FMED covered by FSMEX
35.59%
FSMEX covered by FMED
35.59%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FMED (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| Fidelity Securities Lending Cash Central Fund | 11.15% | |
| DANAHER CORP | 3.77% | |
| UCB SA | 3.61% | |
| BOSTON SCIENTIFIC CORP | 3.58% | |
| ARGENX SE SPONSORED ADR | 3.41% | |
| COGENT BIOSCIENCES INC | 3.40% | |
| ALNYLAM PHARMACEUTICALS INC | 2.94% | |
| INTUITIVE SURGICAL INC | 2.79% | |
| VEEVA SYSTEMS-A | 2.65% | |
| INSULET CORP | 2.29% | |
| MODERNA INC | 2.28% | |
| WAYSTAR HOLDING CORP | 2.24% | |
| EDWARDS LIFESCIENCES CORP | 2.20% | |
| LIFESTANCE HEALTH GROUP INC | 2.18% | |
| VAXCYTE INC | 2.03% | |
| INSMED INC | 1.74% | |
| Sartorius Stedim Biotech S.A. | 1.74% | |
| STRYKER CORP | 1.65% | |
| LILLY ELI and CO | 1.58% | |
| PRIVIA HEALTH GROUP INC | 1.56% | |
| THERMO FISHER SCIENTIFIC INC | 1.55% | |
| LEGEND BIOTECH CORP SPON ADR | 1.53% | |
| 10X GENOMICS INC | 1.51% | |
| PENUMBRA INC | 1.51% | |
| KYMERA THERAPEUTICS INC | 1.33% | |
| STOKE THERAPEUTICS INC | 1.33% | |
| Ascendis Pharma A/S | 1.32% | |
| UNITEDHEALTH GRP | 1.27% | |
| NATERA INC | 1.27% | |
| LONZA GROUP -REG | 1.26% | |
| CYTOKINETICS INC | 1.20% | |
| CARIS LIFE SCIENCES INC | 1.17% | |
| CRINETICS PHARMACEUTICALS INC | 1.14% | |
| DEXCOM INC | 1.12% | |
| DISC MEDICINE INC | 1.08% | |
| VERACYTE INC | 1.07% | |
| RESMED INC | 1.05% | |
| XENON PHARMACEUTICALS INC | 0.99% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 0.89% | |
| NUVALENT INC-A | 0.89% | |
| CYTOMX THERAPEUTICS INC | 0.88% | |
| ALIGNMENT HEALTHCARE INC | 0.84% | |
| ALIGN TECHNOLOGY INC | 0.83% | |
| GUARDANT HEALTH INC | 0.82% | |
| WAVE LIFE SCIENCES LTD | 0.81% | |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 0.78% | |
| ROIVANT SCIENCES LTD | 0.76% | |
| REPLIGEN CORP | 0.74% | |
| ENLIVEN THERAPEUTICS INC | 0.74% | |
| BIO-TECHNE CORP | 0.72% |
FSMEX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| DANAHER CORP | 13.66% | |
| BOSTON SCIENTIFIC CORP | 12.35% | |
| THERMO FISHER SCIENTIFIC INC | 9.59% | |
| INTUITIVE SURGICAL INC | 8.71% | |
| EDWARDS LIFESCIENCES CORP | 5.61% | |
| STRYKER CORP | 4.95% | |
| ABBOTT LABS | 4.89% | |
| MASIMO CORP | 2.70% | |
| VEEVA SYSTEMS-A | 2.64% | |
| INSULET CORP | 2.44% | |
| IQVIA HOLDINGS INC | 2.21% | |
| WAYSTAR HOLDING CORP | 1.97% | |
| REPLIGEN CORP | 1.91% | |
| BIO-TECHNE CORP | 1.75% | |
| WATERS CORP | 1.58% | |
| Sartorius Stedim Biotech S.A. | 1.55% | |
| BECTON DICKINSON and CO | 1.54% | |
| CARIS LIFE SCIENCES INC | 1.49% | |
| MEDLINE INC-A | 1.36% | |
| IRHYTHM TECHNOLOGIES INC | 1.35% | |
| 10X GENOMICS INC | 1.25% | |
| NATERA INC | 1.14% | |
| PENUMBRA INC | 1.14% | |
| VERACYTE INC | 1.06% | |
| GUARDANT HEALTH INC | 1.06% | |
| AGILENT TECHNOLOGIES INC | 1.00% | |
| GE HEALTHCARE TECHNOLOGIES INC WI | 0.97% | |
| Fidelity Securities Lending Cash Central Fund | 0.93% | |
| KARDIUM SRE D-7 PC PP (REDOMICILE CLOSING AUGUST 2025) | 0.92% | |
| LIFESTANCE HEALTH GROUP INC | 0.72% | |
| KESTRA MEDICAL TECHNOLOGIES INC | 0.64% | |
| Fidelity Cash Central Fund | 0.62% | |
| HEARTFLOW INC | 0.59% | |
| METTLER-TOLEDO INTL INC | 0.48% | |
| ELEMENT BIOSCIENCES INC SER D PC PP | 0.47% | |
| BRUKER CORP | 0.40% | |
| OMADA HEALTH INC | 0.34% | |
| SHOULDER INNOVATIONS INC(180 Day Lockup) | 0.33% | |
| FREENOME HOLDINGS INC SER D PC PP | 0.32% | |
| 10X GENOMICS INC CL B 144A | 0.25% | |
| ALEDADE INC SER F PC PP | 0.17% | |
| GALVANIZE THERAPEUTICS SER C-1 PC PERP PP | 0.17% | |
| ICU MEDICAL INC | 0.17% | |
| MANUS BIO INC SER ONE-6 PC PP | 0.16% | |
| DNA SCRIPT SAS SER C PC PP | 0.14% | |
| ASIMOV INC SER B PC PP | 0.07% | |
| DOXIMITY INC-A | 0.07% | |
| SALUDA MEDICAL INC WT PP | 0.06% | |
| DMED BIOPHARMACEUTICAL CO LTD SER C PC PP | 0.05% | |
| SALUDA MEDICAL INC CDI | 0.04% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.